DiaMedica Therapeutics Inc.

DMAC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$3,326$4,109$2,589$3,025
Short-Term Investments$51,992$25,929$33,731$41,122
Receivables$260$161$253$236
Inventory$0$0$0$0
Other Curr. Assets$645$880$849$227
Total Curr. Assets$56,223$31,079$37,422$44,610
Property Plant & Equip (Net)$368$391$408$427
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$1,000$0
Tax Assets$0$0$0$0
Other NC Assets$456$0$0$1,308
Total NC Assets$824$391$1,408$1,735
Other Assets$0$0$0$0
Total Assets$57,047$31,470$38,830$46,345
Liabilities
Payables$1,920$1,261$1,507$940
Short-Term Debt$109$108$105$103
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,239$2,747$3,053$4,347
Total Curr. Liab.$5,268$4,116$4,665$5,390
LT Debt$157$184$211$237
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$157$184$211$237
Other Liabilities$0$0$0$0
Cap. Leases$157$292$316$340
Total Liabilities$5,425$4,300$4,876$5,627
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$164,028-$155,408-$147,709-$140,002
AOCI$50-$14$5$23
Other Equity$215,600$182,592$181,658$180,697
Total Equity$51,622$27,170$33,954$40,718
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$57,047$31,470$38,830$46,345
Net Debt-$3,060-$3,817-$2,273-$2,685
DiaMedica Therapeutics Inc. (DMAC) Financial Statements & Key Stats | AlphaPilot